Vector-borne diseases (VBDs) pose a significant public health challenge in India, with a high prevalence rate and substantial morbidity and mortality. This article provides a comprehensive overview of the current landscape of VBDs in India and offers practical guidance for their effective management.
India faces a high burden of VBDs such as Malaria, Dengue, Chikungunya, and Japanese Encephalitis. Climatic conditions, environmental factors, and socio-economic disparities contribute to the widespread prevalence of these diseases. Malaria alone accounts for a significant proportion of morbidity and mortality, with the northeastern states being the most affected.
The management of VBDs in India is fraught with challenges, including inadequate public health infrastructure, lack of awareness, and socio-economic factors. Additionally, the emergence of drug-resistant strains and the lack of effective vaccines for many VBDs further complicate the situation.
Effective management of VBDs requires a multifaceted approach, encompassing robust surveillance, early detection, prompt treatment, and vector control. Strengthening the public health infrastructure, enhancing community awareness, and promoting research for new drugs and vaccines are crucial for managing VBDs.
Healthcare professionals play a pivotal role in the management of VBDs. This includes early diagnosis, appropriate treatment, patient education, and participation in public health initiatives. They also have a crucial role in research and policy-making, contributing to the development of effective strategies for VBD control.
Vector-borne diseases remain a significant public health concern in India, requiring concerted efforts for effective management. Healthcare professionals are at the forefront of these efforts, playing a critical role in disease control and prevention. Continued focus on strengthening public health infrastructure, enhancing community awareness, and research is imperative for managing the burden of VBDs in India.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation